A Brief Overview of Opus Point Partners

1. A Brief Overview of Opus Point
Partners

2. ● Dr. Lindsay Rosenwald co-founded New York-based
biotechnology investment company Opus Point Partners
after a distinguished career as a practicing Philadelphia
physician and as one of the first-ever Wall Street
physician-analysts in the pharmaceutical sector.
● He had previously established or financially developed
companies that include Keryx Biopharmaceuticals, Inc.,
Cypress Bioscience, Inc., and Cougar Biotechnology,
Inc.
● Cougar made headlines in 2009 when Johnson &
Johnson paid nearly $1 billion to acquire it while its
innovative prostate cancer treatment drug Zytiga was still
undergoing the phase II clinical trials designed to test its
efficacy.

3. ● Opus Point Partners works to create investment
opportunities through hedge funds that concentrate
on the development of emerging medications, as
well as the health care field in general.
● A joint venture that draws on the extensive medical
and business experience of its founders, Opus Point
Partners strategizes the most effective means of
providing diversified, liquid investment vehicles that
can provide a high rate of return to clients.
● On its website, the company offers up-to-date
reports on the biotechnology investment industry,
including information on clinical trials and regulatory
actions that may affect investors.

4. ● Dr. Lindsay Rosenwald has additionally given
back to his community through the
establishment of the Rosenwald Foundation,
which has made millions of dollars in
charitable contributions.
[Sources:
http://opuspointpartners.com/about_us_more.php?
id_content=2&id=1 ]